Prescriptions for the newest – but more expensive — cholesterol-lowering drugs called PCSK9 inhibitors that are not covered by insurance companies or unfilled by patients are related to higher risk of cardiovascular problems for high risk patients. High co-payments may make patients less likely to fill prescriptions, even if insurers approve them. Prescriptions written for women, blacks and Hispanics were more likely to be rejected.
Related Posts
Order Antibiotics online
June 8, 2024Buying antibiotics online
June 8, 2024How do antibiotics work?
June 8, 2024Flagyl: a beacon of hope in the fight against trichomoniasis
February 17, 2024Metronidazole for bacterial infection
February 1, 2023